| 000 | 01434 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515193107.0 | ||
| 264 | 0 | _c20100308 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/cncr.24720 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHersh, Evan M | |
| 245 | 0 | 0 |
_aA phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma. _h[electronic resource] |
| 260 |
_bCancer _cJan 2010 |
||
| 300 |
_a155-63 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlbumin-Bound Paclitaxel |
| 650 | 0 | 4 |
_aAlbumins _xadverse effects |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aPaclitaxel _xadverse effects |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 700 | 1 | _aO'Day, Steven J | |
| 700 | 1 | _aRibas, Antoni | |
| 700 | 1 | _aSamlowski, Wolfram E | |
| 700 | 1 | _aGordon, Michael S | |
| 700 | 1 | _aShechter, Deganit E | |
| 700 | 1 | _aClawson, Alicia A | |
| 700 | 1 | _aGonzalez, Rene | |
| 773 | 0 |
_tCancer _gvol. 116 _gno. 1 _gp. 155-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cncr.24720 _zAvailable from publisher's website |
| 999 |
_c19265908 _d19265908 |
||